These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7569775)

  • 1. Binding to erythrocyte complement receptor type 1 of BSA/anti-BSA complexes opsonized by C4A3 or C4B1 in the presence of serum.
    Klint C; Truedsson L; Sturfelt G
    Scand J Immunol; 1995 Oct; 42(4):425-32. PubMed ID: 7569775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation of C3 by a casein kinase released from activated human platelets increases opsonization of immune complexes and binding to complement receptor type 1.
    Nilsson-Ekdahl K; Nilsson B
    Eur J Immunol; 2001 Apr; 31(4):1047-54. PubMed ID: 11298329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of immune complexes to erythrocyte CR1 (CD35): difference in requirement of classical pathway components and indication of alternative pathway-mediated binding in C2-deficiency.
    Klint C; Gullstrand B; Sturfelt G; Truedsson L
    Scand J Immunol; 2000 Jul; 52(1):103-8. PubMed ID: 10886790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The fluid-phase binding of human C4 and its genetic variants, C4A3 and C4B1, to immunoglobulins.
    Kishore N; Shah D; Skanes VM; Levine RP
    Mol Immunol; 1988 Sep; 25(9):811-9. PubMed ID: 3264881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of complement-solubilized immune complexes with CR1 receptors on human erythrocytes. The binding reaction.
    Jepsen HH; Svehag SE; Jarlbaek L; Baatrup G
    Scand J Immunol; 1986 Jan; 23(1):65-73. PubMed ID: 2939551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of complement activity by immunoglobulin. I. Effect of immunoglobulin isotype on C4 uptake on antibody-sensitized sheep erythrocytes and solid phase immune complexes.
    Miletic VD; Hester CG; Frank MM
    J Immunol; 1996 Jan; 156(2):749-57. PubMed ID: 8543829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The activation of C3 and C4 in human serum by immune complexes containing mouse monoclonal antibodies of different isotype and affinity: effects on solubilisation.
    Stewart WW; Johnson A; Steward MW; Whaley K; Kerr MA
    Mol Immunol; 1988 Dec; 25(12):1355-61. PubMed ID: 3266294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C4-mediated inhibition of immune precipitation and differences in inhibitory action of genetic variants, C4A3 and C4B1.
    Paul L; Skanes VM; Mayden J; Levine RP
    Complement; 1988; 5(3):110-9. PubMed ID: 3180739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal rheumatoid factor-IgG immune complexes. Poor fixation of opsonic C4 and C3 despite efficient complement activation.
    Ng YC; Peters DK; Walport MJ
    Arthritis Rheum; 1988 Jan; 31(1):99-107. PubMed ID: 3345233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of antibody isotype on the activation of C3 and C4 by immune complexes formed in the presence of serum: correlation with the prevention of immune precipitation.
    Stewart WW; Johnson A; Steward MW; Whaley K; Kerr MA
    Mol Immunol; 1990 May; 27(5):423-8. PubMed ID: 2366759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of processing by erythrocyte C3b/C4b receptors (CR1) on binding of immune complexes to Raji cells and polymorphonuclear granulocytes.
    Rasmussen JM; Jepsen HH; Svehag SE
    Scand J Immunol; 1987 Oct; 26(4):437-44. PubMed ID: 2961050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BSA-anti-BSA immune complexes formed in the presence of human complement do not bind to autologous red blood cells.
    Varga L; Thiry E; Füst G
    Immunology; 1988 Jul; 64(3):381-4. PubMed ID: 3410490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inefficient binding of IgM immune complexes to erythrocyte C3b-C4b receptors (CR1) and weak incorporation of C3b-iC3b into the complexes.
    Kávai M; Rasmussen JM; Baatrup G; Zsindely A; Svehag SE
    Scand J Immunol; 1988 Jul; 28(1):123-8. PubMed ID: 2969612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences between C4A and C4B in the handling of immune complexes: the enhancement of CR1 binding is more important than the inhibition of immunoprecipitation.
    Gatenby PA; Barbosa JE; Lachmann PJ
    Clin Exp Immunol; 1990 Feb; 79(2):158-63. PubMed ID: 2138067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional properties of heterogeneous human asialo-C4 and its isotypes C4A and C4B.
    Schultz DR; Arnold PI
    Immunobiology; 1992 Jun; 185(1):90-102. PubMed ID: 1398744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune complexes and erythrocyte CR1 (complement receptor type 1): effect of CR1 numbers on binding and release reactions.
    Ng YC; Schifferli JA; Walport MJ
    Clin Exp Immunol; 1988 Mar; 71(3):481-5. PubMed ID: 2968204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum complement activation of SLE patients during plasmapheresis.
    Csipö I; Kávai M; Kiss E; Bedö Z; Csongor J; Szegedi G; Philbert F; Cohen JH
    Autoimmunity; 1997; 25(3):139-46. PubMed ID: 9272279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CR1 on erythrocytes of Brazilian systemic lupus erythematosus patients: the influence of disease activity on expression and ability of this receptor to bind immune complexes opsonized with complement from normal human serum.
    Marzocchi-Machado CM; Alves CM; Azzolini AE; Polizello AC; Carvalho IF; Lucisano-Valim YM
    J Autoimmun; 2005 Dec; 25(4):289-97. PubMed ID: 16289666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors influencing the binding of large immune complexes to the primate erythrocyte CR1 receptor.
    Cornacoff JB; Hebert LA; Birmingham DJ; Waxman FJ
    Clin Immunol Immunopathol; 1984 Feb; 30(2):255-64. PubMed ID: 6692603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of immune precipitation by complement.
    Hong K; Takata Y; Sayama K; Kozono H; Takeda J; Nakano Y; Kinoshita T; Inoue K
    J Immunol; 1984 Sep; 133(3):1464-70. PubMed ID: 6747294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.